These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8809230)

  • 1. Leukotriene synthesis inhibition and anti-ige challenge of human lung parenchyma.
    Gorenne I; Alaoui HS; Gascard JP; Labat C; Norel X; De Montpreville V; Brink C
    Life Sci; 1996; 59(13):PL213-9. PubMed ID: 8809230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl] acetic acid (BAY x1005), a potent leukotriene synthesis inhibitor: effects on anti-IgE challenge in human airways.
    Gorenne I; Labat C; Gascard JP; Norel X; Müller-Peddinghaus R; Mohrs KH; Taylor WA; Gardiner PJ; Brink C
    J Pharmacol Exp Ther; 1994 Feb; 268(2):868-72. PubMed ID: 8114000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antigen-induced contraction of guinea-pig airways by a leukotriene synthesis inhibitor, BAY x1005.
    Gardiner PJ; Cuthbert NJ; Francis HP; Fitzgerald MF; Thompson AM; Carpenter TG; Patel UP; Newton BB; Mohrs K; Müller-Peddinghaus R
    Eur J Pharmacol; 1994 Jun; 258(1-2):95-102. PubMed ID: 7925604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of indomethacin on immunologic release of histamine and sulfidopeptide leukotrienes from human bronchus and lung parenchyma.
    Undem BJ; Pickett WC; Lichtenstein LM; Adams GK
    Am Rev Respir Dis; 1987 Nov; 136(5):1183-7. PubMed ID: 2445231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
    Jonsson EW; Dahlén SE
    J Pharmacol Exp Ther; 1994 Nov; 271(2):615-23. PubMed ID: 7965776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological modulation of human platelet leukotriene C4-synthase.
    Sala A; Folco G; Henson PM; Murphy RC
    Biochem Pharmacol; 1997 Mar; 53(6):905-8. PubMed ID: 9113110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors.
    Tagari P; Brideau C; Chan C; Frenette R; Black C; Ford-Hutchinson A
    Agents Actions; 1993 Sep; 40(1-2):62-71. PubMed ID: 8147271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
    Müller-Peddinghaus R; Kohlsdorfer C; Theisen-Popp P; Fruchtmann R; Perzborn E; Beckermann B; Bühner K; Ahr HJ; Mohrs KH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):51-7. PubMed ID: 8229782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel leukotoriene synthesis inhibitor, BAY x1005, on the antigen-and LPS-induced airway hyperresponsiveness in guinea pigs.
    Nagai H; Takeda H; Uno T; Tanaka H; Matsuo A
    Prostaglandins; 1996 Feb; 51(2):139-48. PubMed ID: 8711135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
    Tagari P; Becker A; Brideau C; Frenette R; Sadl V; Thomas E; Vickers P; Ford-Hutchinson A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):416-25. PubMed ID: 8386242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor.
    Larsson AK; Bäck M; Hjoberg J; Dahlén SE
    J Pharmacol Exp Ther; 2005 Oct; 315(1):458-65. PubMed ID: 16024733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
    Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
    Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SCH 37224 on anti-IgE-induced formation of sulfidopeptide leukotrienes in human lung parenchyma.
    Viganò T; Crivellari MT; Accomazzo MR; Monopoli A; Belloni PA; Torre M; Nicosia S; Folco GC
    Eur J Pharmacol; 1992 Aug; 219(1):159-64. PubMed ID: 1397043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.
    Bäck M; Norel X; Walch L; Gascard J; de Montpreville V; Dahlén S; Brink C
    Eur J Pharmacol; 2000 Aug; 401(3):389-95. PubMed ID: 10936498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes.
    Rossoni G; Sala A; Berti F; Testa T; Buccellati C; Molta C; Muller-Peddinghaus R; Maclouf J; Folco GC
    J Pharmacol Exp Ther; 1996 Jan; 276(1):335-41. PubMed ID: 8558451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist activities of the leukotriene analogue BAY u9773 in guinea pig lung parenchyma.
    Wikström Jonsson E; Rosenqvist U; Dahlén SE
    Eur J Pharmacol; 1998 Sep; 357(2-3):203-11. PubMed ID: 9797038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of leukotrienes, induced by the Ca++ ionophore A23187, from human lung parenchyma in vitro.
    Sautebin L; Viganò T; Grassi E; Crivellari MT; Galli G; Berti F; Mezzetti M; Folco G
    J Pharmacol Exp Ther; 1985 Jul; 234(1):217-21. PubMed ID: 2989505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma.
    Vigano T; Toia A; Crivellari MT; Galli G; Mezzetti M; Folco GC
    Eicosanoids; 1988; 1(2):73-7. PubMed ID: 3152489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro.
    Kusner EJ; Marks RL; Aharony D; Krell RD
    Biochem Pharmacol; 1989 Dec; 38(23):4183-9. PubMed ID: 2557041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgE Response in Human Airways: Relative Contribution of Inflammatory Mediators.
    Gorenne I; Labat C; Norel X; Alaoui HS; Gascard JP; Brink C
    Mediators Inflamm; 1994; 3(5):359-63. PubMed ID: 18475581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.